|
x |
|
Quarterly
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
o |
|
Transition
Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of
1934
|
Delaware
|
|
06-0853042
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer Identification Number)
|
3
Great Pasture Road
|
||
06813
|
||
(Address
of Principal Executive Offices)
|
Zip
Code
|
Large
accelerated filer o
|
Accelerated
filer x
|
Non-accelerated
filer o
|
|
Page
|
||
PART I. | FINANCIAL INFORMATION | ||
Item
1.
|
|
Consolidated
Financial Statements (unaudited)
|
|
|
|
Consolidated
Balance Sheets as of April 30, 2008 and October 31, 2007
|
3
|
|
|
Consolidated
Statements of Operations for the three months ended April 30, 2008
and
2007
|
4
|
Consolidated
Statements of Operations for the six months ended April 30, 2008
and
2007
|
5
|
||
Consolidated
Statements of Cash Flows for the six months ended April 30, 2008
and
2007
|
6
|
||
|
|
Notes
to Consolidated Financial Statements
|
7
|
Item
2.
|
|
Management’s
Discussion and Analysis of Financial Condition and Results of Operations
|
17
|
Item
3.
|
|
Quantitative
and Qualitative Disclosures about Market Risk
|
32
|
Item
4.
|
|
Controls
and Procedures
|
33
|
PART II. | OTHER INFORMATION | ||
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
34
|
|
Item 6.
|
|
Exhibits
|
35
|
|
|
Signature
|
36
|
April
30,
2008
(Unaudited)
|
October
31,
2007
|
||||
ASSETS
|
|||||
Current
assets:
|
|||||
Cash
and cash equivalents
|
$
|
68,940
|
$
|
92,997
|
|
Investments:
U.S. treasury securities
|
44,557
|
60,634
|
|||
Accounts
receivable, net of allowance for doubtful accounts of $17 and $63,
respectively
|
12,861
|
10,063
|
|||
Inventories,
net
|
30,953
|
29,581
|
|||
Other
current assets
|
8,588
|
7,730
|
|||
Total
current assets
|
165,899
|
201,005
|
|||
Property,
plant and equipment, net
|
38,169
|
39,612
|
|||
Investments:
U.S. treasury securities
|
8,251
|
—
|
|||
Investment
and loan to affiliate
|
11,177
|
12,216
|
|||
Other
assets, net
|
446
|
355
|
|||
Total
assets
|
$
|
223,942
|
$
|
253,188
|
|
|
|||||
LIABILITIES
AND SHAREHOLDERS’ EQUITY
|
|||||
Current
liabilities:
|
|||||
Current
portion of long-term debt and other liabilities
|
$
|
781
|
$
|
924
|
|
Accounts
payable
|
14,021
|
9,516
|
|||
Accounts
payable due to affiliate
|
3,003
|
2,881
|
|||
Accrued
liabilities
|
8,257
|
8,511
|
|||
Deferred
license fee income
|
600
|
—
|
|||
Deferred
revenue and customer deposits
|
26,140
|
20,486
|
|||
Total
current liabilities
|
52,802
|
42,318
|
|||
Long-term
deferred revenue
|
3,495
|
4,401
|
|||
Long-term
debt and other liabilities
|
1,105
|
613
|
|||
Total
liabilities
|
57,402
|
47,332
|
|||
Redeemable
minority interest
|
12,559
|
11,884
|
|||
Redeemable
preferred stock ($0.01 par value, liquidation preference of $64,120
at April 30, 2008 and October 31, 2007.)
|
59,950
|
59,950
|
|||
Shareholders’
equity:
|
|||||
Common
stock ($.0001 par value); 150,000,000 shares authorized at April
30, 2008
and October 31, 2007; 68,620,459
and 68,085,059 shares issued and outstanding at April 30, 2008
and October
31, 2007, respectively.
|
7
|
7
|
|||
Additional
paid-in capital
|
575,846
|
571,944
|
|||
Accumulated
deficit
|
(481,822)
|
(437,929)
|
|||
Treasury
stock, Common, at cost (8,981 and 12,282 shares at April 30, 2008
and
October 31, 2007, respectively)
|
(90)
|
(126)
|
|||
Deferred
compensation
|
90
|
126
|
|||
Total
shareholders’ equity
|
94,031
|
134,022
|
|||
Total
liabilities and shareholders’ equity
|
$
|
223,942
|
$
|
253,188
|
Three
Months Ended
April
30,
|
|||||||
2008
|
2007
|
||||||
Revenues:
|
|||||||
Product
sales and revenues
|
$
|
26,440
|
$
|
8,861
|
|||
Research
and development contracts
|
5,203
|
2,522
|
|||||
Total
revenues
|
31,643
|
11,383
|
|||||
Costs
and expenses:
|
|||||||
Cost
of product sales and revenues
|
39,787
|
16,394
|
|||||
Cost
of research and development contracts
|
4,831
|
2,096
|
|||||
Administrative
and selling expenses
|
5,798
|
4,773
|
|||||
Research
and development expenses
|
5,931
|
6,654
|
|||||
Total
costs and expenses
|
56,347
|
29,917
|
|||||
Loss
from operations
|
(24,704
|
)
|
(18,534
|
)
|
|||
Interest
expense
|
(17
|
)
|
(21
|
)
|
|||
Loss
from equity investments
|
(607
|
)
|
(401
|
)
|
|||
Interest
and other income, net
|
824
|
1,373
|
|||||
Loss
before redeemable minority interest
|
(24,504
|
)
|
(17,583
|
)
|
|||
Redeemable
minority interest
|
(473
|
)
|
(421
|
)
|
|||
Loss
before provision for income taxes
|
(24,977
|
)
|
(18,004
|
)
|
|||
Provision
for income taxes
|
—
|
—
|
|||||
Net
loss
|
(24,977
|
)
|
(18,004
|
)
|
|||
|
|||||||
Preferred
stock dividends
|
(802
|
)
|
(802
|
)
|
|||
Net
loss to common shareholders
|
$
|
(25,779
|
)
|
$
|
(18,806
|
)
|
|
Loss
per share basic and diluted:
|
|||||||
Net
loss per share to common shareholders
|
$
|
(0.38
|
)
|
$
|
(0.32
|
)
|
|
Basic
and diluted weighted average shares outstanding
|
68,540,701
|
58,750,006
|
Six
Months Ended
April
30,
|
|||||||
2008
|
2007
|
||||||
Revenues:
|
|||||||
Product
sales and revenues
|
$
|
36,208
|
$
|
13,760
|
|||
Research
and development contracts
|
10,454
|
4,457
|
|||||
Total
revenues
|
46,662
|
18,217
|
|||||
Costs
and expenses:
|
|||||||
Cost
of product sales and revenues
|
59,197
|
29,776
|
|||||
Cost
of research and development contracts
|
9,271
|
4,040
|
|||||
Administrative
and selling expenses
|
10,610
|
9,190
|
|||||
Research
and development expenses
|
11,416
|
13,509
|
|||||
Total
costs and expenses
|
90,494
|
56,515
|
|||||
Loss
from operations
|
(43,832
|
)
|
(38,298
|
)
|
|||
License
fee income, net
|
—
|
34
|
|||||
Interest
expense
|
(49
|
)
|
(48
|
)
|
|||
Loss
from equity investments
|
(1,050
|
)
|
(618
|
)
|
|||
Interest
and other income, net
|
1,949
|
2,502
|
|||||
Loss
before redeemable minority interest
|
(42,982
|
)
|
(36,428
|
)
|
|||
Redeemable
minority interest
|
(911
|
)
|
(812
|
)
|
|||
Loss
before provision for income taxes
|
(43,893
|
)
|
(37,240
|
)
|
|||
Provision
for income taxes
|
—
|
—
|
|||||
Net
loss
|
(43,893
|
)
|
(37,240
|
)
|
|||
|
|||||||
Preferred
stock dividends
|
(1,604
|
)
|
(1,604
|
)
|
|||
Net
loss to common shareholders
|
$
|
(45,497
|
)
|
$
|
(38,844
|
)
|
|
Loss
per share basic and diluted:
|
|||||||
Net
loss per share to common shareholders
|
$
|
(0.67
|
)
|
$
|
(0.69
|
)
|
|
Basic
and diluted weighted average shares outstanding
|
68,396,064
|
55,914,872
|
Six
Months Ended
April
30,
|
|||||||
2008
|
2007
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(43,893
|
)
|
$
|
(37,240
|
)
|
|
Adjustments
to reconcile net loss to net cash used in
|
|||||||
operating
activities:
|
|||||||
Stock-based
compensation
|
2,886
|
2,693
|
|||||
Loss
in equity investments
|
1,050
|
618
|
|||||
Loss
on redeemable minority interest
|
911
|
812
|
|||||
Interest
receivable on loan to affiliate
|
(85
|
)
|
—
|
||||
Asset
Impairment
|
179
|
—
|
|||||
(Gain)
Loss on derivative
|
(138
|
)
|
24
|
||||
Depreciation
|
4,387
|
4,729
|
|||||
Amortization
(accretion) of bond premium (discount)
|
101
|
(425
|
)
|
||||
Provision
for doubtful accounts
|
(46
|
)
|
62
|
||||
(Increase)
decrease in operating assets:
|
|||||||
Accounts
receivable
|
(2,752
|
)
|
(1,085
|
)
|
|||
Inventories
|
(1,372
|
)
|
(2,622
|
)
|
|||
Other
assets
|
(1,256
|
)
|
(2,499
|
)
|
|||
Increase
(decrease) in operating liabilities:
|
|||||||
Accounts
payable
|
4,627
|
(3,587
|
)
|
||||
Accrued
liabilities
|
942
|
1,324
|
|||||
Deferred
revenue and customer deposits
|
4,748
|
2,150
|
|||||
Deferred
license fee income and other
|
600
|
(38
|
)
|
||||
Net
cash used in operating activities
|
(29,111
|
)
|
(35,084
|
)
|
|||
Cash
flows from investing activities:
|
|||||||
Capital
expenditures
|
(3,028
|
)
|
(2,683
|
)
|
|||
Treasury
notes matured
|
27,100
|
54,000
|
|||||
Treasury
notes purchased
|
(19,375
|
)
|
(30,694
|
)
|
|||
Net
cash provided by investing activities
|
4,697
|
20,623
|
|||||
Cash
flows from financing activities:
|
|||||||
Repayment
of debt
|
(252
|
)
|
(205
|
)
|
|||
Proceeds
from debt
|
628
|
354
|
|||||
Payment
of preferred dividends
|
(1,841
|
)
|
(1,885
|
)
|
|||
Net
proceeds from sale of common stock
|
1,018
|
95,457
|
|||||
Common
stock issued for option and stock purchase plans
|
804
|
1,762
|
|||||
Net
cash provided by financing activities
|
357
|
95,483
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
(24,057
|
)
|
81,022
|
||||
Cash
and cash equivalents-beginning of period
|
92,997
|
26,247
|
|||||
Cash
and cash equivalents-end of period
|
$
|
68,940
|
$
|
107,269
|
|
Amortized
Cost
|
Gross
Unrealized
Gains
|
Gross
Unrealized
(Losses)
|
Fair
Value
|
|||||||||
At
April 30, 2008
|
|||||||||||||
U.S.
government obligations
|
$
|
52,808
|
$
|
120
|
$
|
(55
|
)
|
$
|
52,873
|
||||
At
October 31, 2007
|
|||||||||||||
U.S.
government obligations
|
$
|
60,634
|
$
|
71
|
$
|
(1
|
)
|
$
|
60,704
|
April
30,
|
October
31,
|
||||||
2008
|
2007
|
||||||
Short-term
investments
|
$
|
44,557
|
$
|
60,634
|
|||
Long-term
investments
|
8,251
|
—
|
|||||
Total
|
$
|
52,808
|
$
|
60,634
|
April
30,
|
October
31,
|
||||||
2008
|
2007
|
||||||
Raw
materials
|
$
|
11,323
|
$
|
8,682
|
|||
Work-in-process
|
19,630
|
20,899
|
|||||
Total
|
$
|
30,953
|
$
|
29,581
|
April
30,
2008
|
October
31,
2007
|
Estimated
Useful
Life
|
||||||||
Land
|
$
|
524
|
$
|
524
|
—
|
|||||
Building
and improvements
|
6,638
|
6,454
|
10-26
years
|
|||||||
Machinery,
equipment and software
|
57,024
|
53,449
|
3-8
years
|
|||||||
Furniture
and fixtures
|
2,493
|
2,468
|
10
years
|
|||||||
Equipment
leased to others
|
—
|
2,063
|
3
years
|
|||||||
Power
plants for use under power purchase agreements
|
17,743
|
17,743
|
10
years
|
|||||||
Construction
in progress
|
4,098
|
5,009
|
||||||||
88,520
|
87,710
|
|||||||||
Less,
accumulated depreciation and amortization
|
(50,351
|
)
|
(48,098
|
)
|
||||||
Total
|
$
|
38,169
|
$
|
39,612
|
|
Three
Months Ended
April
30,
|
Six
Months Ended
April
30,
|
|||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Cost
of product sales and revenues
|
$
|
256
|
$
|
178
|
$
|
479
|
$
|
379
|
|||||
Cost
of research and development contracts
|
67
|
71
|
140
|
138
|
|||||||||
General
and administrative expense
|
1,035
|
868
|
1,746
|
1,597
|
|||||||||
Research
and development expense
|
261
|
267
|
493
|
557
|
|||||||||
Total
share-based compensation
|
$
|
1,619
|
$
|
1,384
|
$
|
2,858
|
$
|
2,671
|
Three
Months Ended
April
30,
|
Six
Months Ended
April
30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Expected
life (in years)
|
6.6
|
6.5
|
6.7
|
6.5
|
|||||||||
Risk-free
interest rate
|
2.94
|
%
|
4.54
|
%
|
3.18
|
%
|
4.54
|
%
|
|||||
Volatility
|
67.2
|
%
|
61.5
|
%
|
64.1
|
%
|
61.5
|
%
|
|||||
Dividend
yield
|
—
|
—
|
—
|
—
|
Number
of
options
|
Weighted
average
option
price
|
||||||
Outstanding
at October 31, 2007
|
5,325,341
|
$
|
11.11
|
||||
Granted
|
1,201,305
|
8.60
|
|||||
Exercised
|
(296,725
|
)
|
2.83
|
||||
Forfeited/Cancelled
|
(70,213
|
)
|
11.69
|
||||
Outstanding
at April 30, 2008
|
6,159,708
|
$
|
11.02
|
Options
Outstanding
|
Options
Exercisable
|
|||||||||||||||
Range
of exercise
prices
|
Number
outstanding
|
Weighted
average
remaining
contractual
life
(years)
|
Weighted
average
exercise
price
($)
|
Number
exercisable
|
Weighted
average
exercise
price
($)
|
|||||||||||
$0.28 - $5.10
|
106,000
|
0.9
|
1.63
|
106,000
|
1.63
|
|||||||||||
$5.11 - $9.92
|
3,538,672
|
8.0
|
7.96
|
1,476,040
|
7.64
|
|||||||||||
$9.93
- $14.74
|
1,707,918
|
6.0
|
12.12
|
1,315,740
|
12.61
|
|||||||||||
$14.75
- $19.56
|
314,118
|
2.9
|
16.84
|
313,618
|
16.84
|
|||||||||||
$19.57
- $24.39
|
237,000
|
2.9
|
23.01
|
237,000
|
23.01
|
|||||||||||
$24.40
- $29.21
|
27,000
|
2.7
|
26.15
|
27,000
|
26.15
|
|||||||||||
$29.22
- $34.03
|
165,000
|
2.6
|
29.91
|
165,000
|
29.91
|
|||||||||||
$34.04
- $48.49
|
64,000
|
2.5
|
38.50
|
64,000
|
38.50
|
|||||||||||
6,159,708
|
6.6
|
11.02
|
3,704,398
|
12.66
|
Number
of
Shares
|
||||
Balance
at October 31, 2007
|
308,270
|
|||
Issued
@ $5.67
|
(25,716
|
)
|
||
Balance
at April 30, 2008
|
282,554
|
Six months ended
April 30, 2008
|
||||
Expected
life (in years)
|
.5
|
|||
Risk-free
interest rate
|
3.95
|
%
|
||
Volatility
|
70
|
%
|
||
Dividend
yield
|
—
|
Balance
at October 31, 2007
|
$
|
134,022
|
||
Increase
in additional paid-in-capital for stock-based compensation
|
2,886
|
|||
Increase
in additional paid-in-capital for stock issued under employee benefit
plans
|
2,003
|
|||
Common
stock sales
|
617
|
|||
Series
B Preferred dividends
|
(1,604
|
)
|
||
Net
loss
|
(43,893
|
)
|
||
Balance
at April 30, 2008
|
$
|
94,031
|
Three
months ended
April
30,
|
Six
months ended
April
30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Revenues:
|
|||||||||||||
United
States
|
$
|
12,018
|
$
|
5,924
|
$
|
21,770
|
$
|
12,162
|
|||||
South
Korea
|
18,213
|
*
|
22,940
|
*
|
|||||||||
Canada
|
*
|
3,513
|
*
|
3,513
|
|||||||||
Germany
|
*
|
1,581
|
*
|
*
|
Three
months ended
April
30,
|
Six
months ended
April
30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Weighted
average basic common
shares
|
68,540,701
|
58,750,006
|
68,396,064
|
55,914,872
|
|||||||||
Effect
of dilutive securities(1)
|
—
|
—
|
—
|
—
|
|||||||||
Weighted
average basic common shares adjusted for diluted calculations
|
68,540,701
|
58,750,006
|
68,396,064
|
55,914,872
|
(1)
|
We
computed earnings per share without consideration of potentially
dilutive
instruments because losses incurred would make them antidilutive.
Future
potentially dilutive stock options that were in-the-money at April
30,
2008 and 2007 totaled 3,211,622 and 1,553,308, respectively. Future
potentially dilutive stock options that were not in-the-money at
April 30,
2008 and 2007 totaled 2,948,086 and 3,788,018, respectively. We also
have
future potentially dilutive warrants issued, which vest and expire
over
time. As of April 30, 2008, 37,500 warrants were vested with an exercise
price of $9.89 and we also had 750,000 unvested
warrants.
|
Six
Months Ended
April
30,
|
|||||||
2008
|
2007
|
||||||
Cash
paid during the period for:
|
|||||||
Interest
|
$
|
50
|
$
|
49
|
|||
Supplemental
disclosure of non-cash investing and financing activities:
|
|||||||
Accrued
Employee Stock Purchase Plan
|
$
|
146
|
$
|
128
|
|||
Accrued
Common Stock Issued for Bonus Incentive
|
$
|
1,050
|
$
|
942
|
|||
Impact
on investing activities resulting from the sale of the power plant
used
under a PPA to Sierra Nevada Brewing Co.(1)
|
$
|
—
|
$
|
(3,943
|
)
|
(1)
|
In
December 2006, we completed the sale of the 1 MW power plant that
had been
operating under a power purchase agreement to the Sierra Nevada Brewing
Co. The net book value of the asset of approximately $3.9 million,
that
was recorded in property, plant and equipment as of October 31, 2006,
was
recorded in cost of product sales and revenues upon the sale of the
asset.
In addition, this sale resulted in the assumption by the buyer of
certain
of our incentive fund liabilities resulting in a $2.2 million decrease
in
deferred revenue liabilities, which was recorded in cost of product
sales
and revenues.
|
·
|
Ultra-clean
(e.g. virtually zero emissions), quiet
operation
|
·
|
High
fuel efficiency
|
·
|
Reliable,
24/7 baseload power
|
·
|
Ability
to site units locally
|
·
|
Potentially
lower cost power generation
|
·
|
Byproduct
heat ideal for cogeneration (combined heat and power)
applications.
|
·
|
POSCO
Power ordered 2 DFC3000 power plants (4.8 MW) during the first
quarter.
|
·
|
Eastern
Municipal Water District (EMWD) in southern California ordered 3
DFC300
power plants (0.75 MW) to provide power for its wastewater
operations.
|
·
|
The
Linde Group, the world’s largest industrial gases company, ordered a
DFC300 and 3 DFC1500 power plants (3.9
MW).
|
·
|
POSCO
Power ordered 25.6 MW of MW-class power plants and modules for delivery
in
2009. This order is valued at approximately $70.0 million. In the
near
term, we will ship complete power plants to POSCO Power. In 2009,
we will
begin to ship modules, together with a complete set of balance of
plant
components. POSCON (a POSCO affiliate company) will do the balance
of
plant assembly with our technical support. Starting in September
2009, we
will begin to ship modules only, and POSCO will be responsible for
procurement and manufacturing of all balance of plant components.
POSCO Power has now ordered a total of 38.2 MW of FuelCell Energy
products
since signing our 10-year agreement in February
2007.
|
·
|
CFC
Solutions ordered stack components totaling approximately 0.8
MW.
|
Three Months Ended
April
30, 2008
|
Three Months Ended
April
30, 2007
|
Percentage
Increase in Revenues
|
||||||||||||||
|
Revenues
|
Percent of
Revenues
|
Revenues
|
Percent of
Revenues
|
||||||||||||
Revenues: | ||||||||||||||||
Product
sales and revenues
|
$
|
26,440
|
84
|
%
|
$
|
8,861
|
78
|
%
|
198
|
%
|
||||||
Research
and development contracts
|
5,203
|
16
|
%
|
2,522
|
22
|
%
|
106
|
%
|
||||||||
Total
|
$
|
31,643
|
100
|
%
|
$
|
11,383
|
100
|
%
|
178
|
%
|
Three Months Ended
April 30, 2008
|
Three Months Ended
April 30, 2007
|
Percentage
Increase
in Cost of
Revenues
|
||||||||||||||
|
Cost of
Revenues
|
Percent of
Cost of
Revenues
|
Cost of
Revenues
|
Percent of
Cost of
Revenues
|
||||||||||||
Cost of revenues: | ||||||||||||||||
Product
sales and revenues
|
$
|
39,787
|
89
|
%
|
$
|
16,394
|
89
|
%
|
143
|
%
|
||||||
Research
and development contracts
|
4,831
|
11
|
%
|
2,096
|
11
|
%
|
130
|
%
|
||||||||
Total
|
$
|
44,618
|
100
|
%
|
$
|
18,490
|
100
|
%
|
141
|
%
|
Six Months Ended
April 30, 2008
|
Six Months Ended
April 30, 2007
|
Percentage
Increase /
|
||||||||||||||
Revenues
|
|
Percent of
Revenues
|
|
Revenues
|
|
Percent of
Revenues
|
|
(Decrease) in
Revenues
|
||||||||
Revenues:
|
||||||||||||||||
Product
sales and revenues
|
$
|
36,208
|
78
|
%
|
$
|
13,760
|
76
|
%
|
163
|
%
|
||||||
Research
and development contracts
|
10,454
|
22
|
%
|
4,457
|
24
|
%
|
135
|
%
|
||||||||
Total
|
46,662
|
100
|
%
|
$
|
18,217
|
100
|
%
|
156
|
%
|
Six Months Ended
April 30, 2008
|
Six Months Ended
April 30, 2007
|
Percentage
Increase /
|
||||||||||||||
Cost of
Revenues
|
|
Percent of
Cost of
Revenues
|
|
Cost of
Revenues
|
|
Percent of
Cost of
Revenues
|
|
(Decrease)
in Cost of
Revenues
|
||||||||
Cost
of revenues:
|
||||||||||||||||
Product
sales and revenues
|
59,197
|
86
|
%
|
$
|
29,776
|
88
|
%
|
99
|
%
|
|||||||
Research
and development contracts
|
9,271
|
14
|
%
|
4,040
|
12
|
%
|
129
|
%
|
||||||||
Total
|
68,468
|
100
|
%
|
$
|
33,816
|
100
|
%
|
102
|
%
|
·
|
engineering
improvements;
|
·
|
technology
advances;
|
·
|
supply
chain management;
|
·
|
production
volume; and
|
·
|
manufacturing
process improvements
|
Payments Due by Period
|
|||||||||||||||||||
Contractual
Obligation:
|
Total
|
Less
than
1 Year
|
1 – 3
Years
|
3 – 5
Years
|
More
than
5 Years
|
||||||||||||||
Capital
and operating lease commitments (1)
|
$
|
3,917
|
$
|
963
|
$
|
1,310
|
$
|
897
|
$
|
747
|
|||||||||
Term
loans (principal and interest)
|
1,522
|
720
|
158
|
182
|
462
|
||||||||||||||
Purchase
commitments(2)
|
57,199
|
57,061
|
138
|
—
|
—
|
||||||||||||||
Series
I Preferred dividends payable (3)
|
24,546
|
494
|
12,947
|
2,468
|
8,637
|
||||||||||||||
Series
B Preferred dividends payable (4)
|
5,655
|
3,206
|
2,449
|
—
|
—
|
||||||||||||||
Totals
|
$
|
92,839
|
$
|
62,444
|
$
|
17,002
|
$
|
3,547
|
$
|
9,846
|
(1)
|
Future
minimum lease payments on capital and operating
leases.
|
(2)
|
Purchase
commitments with suppliers for materials supplies, and services incurred
in the normal course of business.
|
(3)
|
Quarterly
dividends of Cdn.$312,500 accrue on the Series 1 preferred shares
(subject
to possible reduction pursuant to the terms of the Series 1 preferred
shares on account of increases in the price of our common stock).
We have
agreed to pay a minimum of Cdn.$500,000 in cash or common stock annually
to Enbridge, Inc., the holder of the Series 1 preferred shares, so
long as
Enbridge holds the shares. Interest accrues on cumulative unpaid
dividends
at a 2.45 percent quarterly rate, compounded quarterly, until payment
thereof. Using an exchange rate of Cdn.$.9871 to U.S.$1.00 (exchange
rate
on April 30, 2008), cumulative unpaid dividends and accrued interest
of
approximately $7.8 million on the Series 1 preferred shares were
outstanding as of April 30, 2008. For
the purposes of this disclosure, we have assumed an exchange rate
of
Cdn.$.9871 to U.S.$1.00 (exchange rate on April 30, 2008) and that
the
minimum dividend payments would be made through 2010. In 2010, we
would be
required to pay any unpaid and accrued dividends. Subsequent to 2010,
we
would be required to pay annual dividend amounts totaling Cdn.$1.25
million. We have the option of paying these dividends in stock or
cash.
|
(4)
|
Dividends
on Series B Preferred Stock accrue at an annual rate of 5% paid quarterly.
The obligations schedule assumes we will pay preferred dividends
on these
shares through November 20, 2009, at which time the preferred shares
may
be subject to mandatory conversion at the option of the Company.
|
NAME OF DIRECTOR
|
VOTES
FOR
|
VOTES
WITHHELD
|
|||||
R.
Daniel Brdar
|
54,439,774
|
682,450
|
|||||
Christof
Von Branconi
|
50,199,377
|
4,922,847
|
|||||
Richard
A. Bromley
|
54,430,187
|
692,037
|
|||||
Glenn
H. Epstein
|
54,439,318
|
682,906
|
|||||
James
D. Gerson
|
54,392,494
|
729,730
|
|||||
Thomas
L. Kempner
|
54,259,147
|
863,077
|
|||||
William
A. Lawson
|
54,381,311
|
740,913
|
|||||
George
K. Petty
|
54,264,835
|
857,389
|
|||||
John
A. Rolls
|
54,453,650
|
668,574
|
|||||
Togo
Dennis West, Jr.
|
54,441,471
|
680,753
|
VOTES
FOR
|
54,812,028
|
|||
VOTES
AGAINST
|
203,787
|
|||
ABSTAINED
|
106,409
|
Exhibit
No.
|
Description
|
|
31.1
|
CEO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
31.2
|
CFO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
32.1
|
|
CEO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act
of
2002
|
32.2
|
|
CFO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act
of
2002
|
FUELCELL
ENERGY, INC.
|
||
(Registrant)
|
||
June
9, 2008
|
|
/s/
Joseph G. Mahler
|
Date
|
|
Joseph
G. Mahler
Senior
Vice President, Chief Financial
Officer,
Treasurer and Corporate Secretary
(Principal Financial Officer and Principal Accounting Officer)
|
Exhibit
No.
|
Description
|
|
31.1
|
CEO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
31.2
|
CFO
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of
2002
|
|
32.1
|
|
CEO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act
of
2002
|
32.2
|
|
CFO
Certification pursuant to Section 906 of the Sarbanes-Oxley Act
of
2002
|